0001104659-20-069071.txt : 20200602 0001104659-20-069071.hdr.sgml : 20200602 20200602185250 ACCESSION NUMBER: 0001104659-20-069071 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200601 FILED AS OF DATE: 20200602 DATE AS OF CHANGE: 20200602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harrison Seth Loring CENTRAL INDEX KEY: 0001404955 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38944 FILM NUMBER: 20938517 MAIL ADDRESS: STREET 1: 230 PARK AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10169 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akero Therapeutics, Inc. CENTRAL INDEX KEY: 0001744659 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 170 HARBOR WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-487-6488 MAIL ADDRESS: STREET 1: 170 HARBOR WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 a4.xml 4 X0306 4 2020-06-01 0 0001744659 Akero Therapeutics, Inc. AKRO 0001404955 Harrison Seth Loring C/O AKERO THERAPEUTICS, INC., 170 HARBOR WAY, 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 1 0 1 0 Stock Option (Right to Buy) 25.20 2020-06-01 4 A 0 13000 0 A 2030-05-31 Common Stock 13000 13000 D This option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director. Under the Reporting Person's arrangement with Apple Tree Venture Management, LLC (the "Management Company"), the Reporting Person holds the option for the benefit of Apple Tree Partners IV, L.P. (the "Fund"). The Reporting Person is obligated to turn over to the Management Company any net cash received upon exercise of the option and sale of the underlying common stock, which will offset management fees owed by the Fund to the Management Company. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock. /s/ Jonathan Young, attorney-in-fact 2020-06-02